Mesotherapy Market Size to Hit USD 1,552.28 Million by 2034
by The global mesotherapy market size was evaluated at USD 764.46 million in 2024 and is predicted to hit around USD 1,552.28 million by 2034, growing …
Category: Healthcare
Exosome Isolation Market Size to Hit USD 1,244.80 Million by 2034
The global exosome isolation market size was valued at USD 413.91 million in 2024 and is expected to hit around USD1,244.80 million by 2034, growing …
Oligonucleotides Market Size to Hit USD 14.54 Billion by 2034
The global oligonucleotides market size is estimated to hit around USD 14.54 billion by 2034 increasing from USD 4.23 billion in 2024, with a CAGR …
Ablation Devices Market Size to Hit USD 24.62 Billion by 2034
The global ablation devices market size was evaluated at USD 9.90 billion in 2024 and is predicted to hit around USD 24.62 billion by 2034, …
Kidney Transplant Market Size to Hit USD 18.29 Billion by 2034
The global kidney transplant market size is estimated to hit around USD 18.29 billion by 2034 increasing from USD 9.27 billion in 2024, with a …
Digital Health Market Size to Surpass USD 1,093.65 Billion by 2034
The digital health market size was evaluated at USD 309.93 billion in 2024 and is predicted to be worth around USD 1,093.65 billion by 2034 …
Pharmaceutical Market Size to Hit USD 3.03 Trillion by 2034
The global pharmaceutical market size is estimated to hit around USD 3.03 trillion by 2034, increasing from USD 1.67 trillion in 2024, with a CAGR …
Biologics Market Size to Hit USD 1,144.20 Billion by 2034
The global biologics market was valued at USD 444.40 billion in 2024 and is expected to hit around USD 1,144.20 billion by 2034, growing at …
Bimekizumab Market Size to Hit USD 8.10 Billion by 2034
The global bimekizumab (BIMZELX) market size was evaluated at USD 1.24 billion in 2024 and is predicted to hit around USD 8.10 billion by 2034, …
Genetic Editing for ASCVD Market Size, Report by 2034
The genetic editing for ASCVD market booming PCSK9-targeted base editing, lipid nanoparticle delivery and next gen CRISPR therapies reshaping LDL control. Genetic Editing for ASCVD …